| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.0015 |
1 |
| mRNA |
GDC-0941 |
FIMM |
pan-cancer |
AAC |
0.0071 |
1 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0016 |
1 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
| mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.001 |
1 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0011 |
1 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
0.0013 |
1 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.00097 |
1 |